You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Details for New Drug Application (NDA): 005509


✉ Email this page to a colleague

« Back to Dashboard


NDA 005509 describes DICUMAROL, which is a drug marketed by Lilly and Abbvie and is included in two NDAs. Additional details are available on the DICUMAROL profile page.

The generic ingredient in DICUMAROL is dicumarol. There is one drug master file entry for this compound. Additional details are available on the dicumarol profile page.
Summary for 005509
Tradename:DICUMAROL
Applicant:Lilly
Ingredient:dicumarol
Patents:0
Medical Subject Heading (MeSH) Categories for 005509

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.